Abstract

The presence of muscle weakness after the administration of a neuromuscular reversal agent is described as a residual neuromuscular blockade (RNMB) due to an incomplete antagonism of a neuromuscular blocker. To decrease the incidence of RNMB, the American Society of Anesthesiologists (ASA) strongly recommends quantitatively monitoring the degree of neuromuscular blockade perioperatively and extubating the patient when the train-of-four (TOF) ratio is greater than or equal to 0.9 at the adductor pollicis. There are acceleromyography (AMG) based and electromyography (EMG) based quantitative monitors; the limitations of AMG have been addressed by EMG.

Author Details

Jada Parish, BSN; Amy Snow, DNP, CRNA

Sigma Membership

Non-member

Type

DNP Capstone Project

Format Type

Text-based Document

Study Design/Type

Case Study/Series

Research Approach

Translational Research/Evidence-based Practice

Keywords:

Residual Neuromuscular Blockade, Electromyography, Acceleromyography

Advisor

Allyson Maddox

Degree

DNP

Degree Grantor

Samford University

Degree Year

2025

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record. All permission requests should be directed accordingly and not to the Sigma Repository. All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Review Type

None: Degree-based Submission

Acquisition

Proxy-submission

Full Text of Presentation

wf_yes

Download
Poster

Additional Files

Abstract.pdf (137 kB)

Figure1.pdf (138 kB)

Share

COinS